BRIEF-ADAR1 Capital Management Calls For Keros Therapeutics To Restructure Business, Reduce Headcount
Reuters
May 09, 2025
BRIEF-ADAR1 Capital Management Calls For Keros <a href="https://laohu8.com/S/LENZ">Therapeutics</a> To Restructure Business, Reduce Headcount
May 8 (Reuters) - ADAR1 Capital Management:
ADAR1 CAPITAL MANAGEMENT: CALLS FOR KEROS TO RESTRUCTURE BUSINESS, SIGNIFICANTLY REDUCE HEADCOUNT, RETURN EXCESS CAPITAL TO STOCKHOLDERS
ADAR1 CAPITAL MANAGEMENT: TO "WITHHOLD" VOTES ON RE-ELECTION OF MARY ANN GRAY & ALPNA SETH AT KEROS THERAPEUTICS' ANNUAL MEETING OF STOCKHOLDERS
ADAR1 CAPITAL MANAGEMENT: URGED KEROS TO DISCONTINUE DEVELOPMENT OF KER-012 AND KER-065
Source text: ID:nPn3C2GWma
Further company coverage: KROS.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.